October 20, 2022 | |
The Secretary | |
BSE Limited | |
P.J. Towers - 25th Floor | |
Dalal Street | Scrip Code: 500830 |
Mumbai-400001 | |
The Manager - Listing Department | |
National Stock Exchange of India Limited | Symbol: COLPAL |
Exchange Plaza, C-1, Block - G | Series: EQ |
Bandra-Kurla Complex | |
Bandra (East), Mumbai 400 051 | |
Dear Sir(s), |
Re: Unaudited Financial Results for the quarter ended September 30, 2022 and Outcome of Board Meeting - October 20, 2022
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors at their meeting held today i.e. October 20, 2022, has, inter alia:
- Approved the Unaudited Financial Results for the second quarter ended September 30, 2022. Please find enclosed herewith the following:
- Unaudited Financial Results for the quarter and half year ended September 30, 2022;
- Company's statement on the above financial results; and
- Limited Review Report of the Auditors.
- Declared a First Interim Dividend of Rs. 18/- (Rupees Eighteen Only) per equity share of Re.1/- (face value) for the financial year 2022-23. The said interim dividend will be paid on and from November 16, 2022 to those shareholders whose names appear in the Register of Members of the Company as on the Record date i.e. November 1, 2022.
Kindly take the above on record.
Thanking you,
Yours sincerely,
For Colgate-Palmolive (India) Limited
Surender Sharma
Whole-time Director - Legal &
Company Secretary
DIN: 02731373
Encl: a/a
COLGATE-PALMOLIVE (INDIA) LIMITED
CIN: L24200MH1937PLC002700
Regd. Office: Colgate Research Centre, Main Street, Hiranandani Gardens, Powai, Mumbai 400 076
Tel.: (022) 6709 5050, Fax: (022) 2570 5088
Website. www.colgatepalmolive.co.in e-mail ID. investors_grievance@colpal.com
Colgate-Palmolive (India) Limited
Registered Office : Colgate Research Centre, Main Street, Hiranandani Gardens, Powai, Mumbai 400 076
CIN : L24200MH1937PLC002700 | Tel : +91 (22) 6709 5050 | |||||||
STATEMENT OF UNAUDITED RESULTS FOR THE QUARTER AND SIX MONTHS ENDED SEPTEMBER 30, 2022 | ||||||||
(Rs. in Lakhs) | ||||||||
Particulars | Quarter | Quarter | Quarter | Six Months | Six Months | Year | ||
Ended | Ended | Ended | Ended | Ended | Ended | |||
September 30, 2022 | June 30, 2022 | September 30, 2021 | September 30, 2022 | September 30, 2021 | March 31, 2022 | |||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | (Audited) | |||
1 | Income | |||||||
(a) Revenue from operations | ||||||||
(i) Sales (Refer Note 1) | 137,837 | 118,659 | 134,396 | 256,496 | 250,182 | 506,646 | ||
(ii) Other Operating Income | 911 | 1,022 | 846 | 1,933 | 1,657 | 3,332 | ||
(b) Other Income | 1,128 | 1,154 | 651 | 2,282 | 1,172 | 2,626 | ||
Total Income | 139,876 | 120,835 | 135,893 | 260,711 | 253,011 | 512,604 |
- Expenses
(a) Cost of materials consumed | 40,624 | 35,587 | 35,294 | 76,211 | 66,367 | 136,801 | |
(b) Purchases of stock-in-trade | 8,539 | 6,616 | 6,645 | 15,155 | 14,759 | 29,608 | |
(c) Changes in inventories of finished goods, work-in-progress | 1,129 | (1,897) | 2,920 | (768) | (293) | 343 | |
and stock-in-trade | |||||||
(d) Employee benefits expense | 9,453 | 9,371 | 10,468 | 18,824 | 19,966 | 38,513 | |
(e) Finance Cost | 127 | 130 | 150 | 257 | 304 | 589 | |
(f) Depreciation and Amortisation expense | 4,386 | 4,416 | 4,489 | 8,802 | 8,959 | 17,730 | |
(g) Other Expenses | |||||||
(i) Advertising | 15,824 | 16,300 | 18,530 | 32,124 | 34,545 | 64,312 | |
(ii) Others | 22,380 | 21,137 | 21,309 | 43,517 | 40,897 | 83,807 | |
Total Expenses | 102,462 | 91,660 | 99,805 | 194,122 | 185,504 | 371,703 | |
3 | Profit Before Exceptional Item and Tax (1-2) | 37,414 | 29,175 | 36,088 | 66,589 | 67,507 | 140,901 |
4 | Exceptional Item [Expense] (Refer Note 3) | - | 934 | - | 934 | - | - |
5 | Profit Before Tax (3-4) | 37,414 | 28,241 | 36,088 | 65,655 | 67,507 | 140,901 |
- Tax expense (Refer Note 2)
i) Current Tax | 9,714 | 7,601 | 9,726 | 17,315 | 18,238 | 34,479 | |
ii) Deferred Tax | (102) | (327) | (555) | (429) | (971) | (1,410) | |
7 | Net Profit for the period (5-6) | 27,802 | 20,967 | 26,917 | 48,769 | 50,240 | 107,832 |
- Other Comprehensive Income (net of Tax)
Items that will not be reclassified to Profit and Loss
i) Re-measurement gains/(losses) on defined benefit plans | - | - | - | - | - | 624 | |
ii) Tax adjustment on above | - | - | - | - | - | (157) | |
9 | Total comprehensive income for the period (7+8) | 27,802 | 20,967 | 26,917 | 48,769 | 50,240 | 108,299 |
10 | Paid-up Equity Share Capital | 2,720 | 2,720 | 2,720 | 2,720 | 2,720 | 2,720 |
(Face value: Re 1/- per share) | |||||||
11 | Reserve excluding Revaluation Reserve | 170,748 | |||||
12 | Basic and Diluted Earnings per share (of Re 1/- each) (not | 10.22 | 7.71 | 9.90 | 17.93 | 18.47 | 39.65 |
annualised) |
Notes
- Sales, net of GST, for the quarter and six months ended September 30, 2022 increased by 2.6% and 2.5% in comparison to the corresponding period sales, net of GST, of the previous year.
- Tax expense for the quarter ended and year ended March 31, 2022 is net of prior year reversal of Rs. 3,199 Lakhs, whereas prior year reversals are Nil for the quarter and six months ended September 30, 2022 and September 30, 2021.
- Exceptional Item includes severance and related expenses of Rs. 934 Lakhs (Previous Year : Nil) with respect to certain organisation structure changes.
- The company has declared a First Interim dividend of Rs. 18/-per share aggregating to Rs. 48,957 Lakhs on October 20, 2022 for FY 2022-23 which will be paid on and from November 16, 2022.
- The Company has identified 'Personal Care (including Oral Care)' as its only primary reportable segment in accordance with the requirements of Ind AS 108, 'Operating Segments'. Accordingly, no separate segment information has been provided.
- Previous period/year figures have been reclassified, as considered necessary, to conform with current period/year presentation, where applicable.
- The Statutory Auditors have carried out a Limited Review of the Financial results of the quarter ended and six months ended September 30, 2022 as required under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above results have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on October 20, 2022.
The full text of Colgate releases is available in the Investors section of our website at www.colgatepalmolive.co.in and is also available on www.bseindia.com and www.nseindia.com.
COLGATE-PALMOLIVE (INDIA) LIMITED
PRABHA | Digitally signed by PRABHA | |
NARASIMHAN | ||
Date: 2022.10.20 13:24:03 | ||
NARASIMHAN +05'30' | ||
PRABHA NARASIMHAN | ||
Mumbai | MANAGING DIRECTOR | |
October 20, 2022 |
Colgate-Palmolive (India) Limited
Registered Office : Colgate Research Centre, Main Street, Hiranandani Gardens, Powai, Mumbai 400 076
CIN : L24200MH1937PLC002700 | Tel : +91 (22) 6709 5050 | ||
BALANCE SHEET AS AT SEPTEMBER 30, 2022 | (Rs. in Lakhs) | ||
As at | As at | ||
Particulars | September 30, 2022 | March 31, 2022 | |
(Unaudited) | (Audited) | ||
ASSETS | |||
(1) Non-current Assets | |||
(a) Property, Plant and Equipment | 91,304 | 96,297 | |
(b) Capital Work-in-progress | 12,160 | 12,184 | |
(c) Financial Assets | |||
i. Loans | 109 | 134 | |
ii. Other Financial Assets | 1,827 | 1,703 | |
(d) Deferred Tax Assets (Net) | 2,158 | 1,730 | |
(e) Other Non-current Assets | 904 | 973 | |
(f) Current Tax Assets (Net) | 28,876 | 28,876 | |
Total Non-current assets | 137,338 | 141,897 | |
(2) Current assets | |||
(a) Inventories | 36,844 | 35,719 | |
(b) Financial Assets | |||
i. Trade Receivables | 14,785 | 22,468 | |
ii. Cash and Cash Equivalents | 92,916 | 72,407 | |
iii. Bank Balances [other than (ii) above] | 3,288 | 3,065 | |
iv. Loans | 676 | 10,732 | |
v. Other Financial Assets | 661 | 700 | |
(c) Other Current Assets | 5,088 | 3,195 | |
Total Current Assets | 154,258 | 148,286 | |
TOTAL ASSETS | 291,596 | 290,183 | |
EQUITY AND LIABILITIES | |||
EQUITY | |||
(a) Equity Share Capital | 2,720 | 2,720 | |
(b) Other Equity | 162,404 | 170,748 | |
TOTAL EQUITY | 165,124 | 173,468 | |
LIABILITIES | |||
(1) Non-current Liabilities | |||
(a) Financial Liabilities | |||
i. Lease Liabilities | 6,872 | 6,901 | |
ii. Other Financial Liabilities | 124 | 124 | |
(b) Provisions | 1,427 | 1,398 | |
(d) Other Non-Current Liabilities | 41 | 45 | |
Total Non-current Liabilities | 8,464 | 8,468 | |
(2) Current Liabilities | |||
(a) Financial Liabilities | |||
i. Lease Liabilities | 1,297 | 1,404 | |
ii. Trade Payables | |||
- Total outstanding dues of micro | 1,814 | 1,556 | |
enterprises and small enterprises | |||
- Total outstanding dues of creditors other | 85,571 | 75,583 | |
than micro enterprises and small enterprises | |||
iii. Other Financial Liabilities | 3,855 | 3,519 | |
(b) Other Current Liabilities | 9,872 | 12,267 | |
(c) Provisions | 8,095 | 8,402 | |
(d) Current Tax Liabilities (Net) | 7,504 | 5,516 | |
Total Current Liabilities | 118,008 | 108,247 | |
TOTAL LIABILITIES | 126,472 | 116,715 | |
TOTAL EQUITY AND LIABILITIES | 291,596 | 290,183 |
COLGATE-PALMOLIVE (INDIA) LIMITED
Registered Office : Colgate Research Centre, Main Street, Hiranandani Gardens, Powai, Mumbai 400 076
CIN : L24200MH1937PLC002700 | Tel : +91 (22) 6709 5050 | ||
Unaudited Statement of Cash Flow for the six months ended September 30, 2022 | (Rs. In Lakhs) | ||
Particulars | Six Months Ended | Six Months Ended | |
September 30, 2022 | September 30, 2021 | ||
(Unaudited) | (Unaudited) | ||
Cash flow from Operating Activities: | |||
Profit before Tax | 65,655 | 67,507 | |
Adjustment for: | |||
Unrealised Foreign Exchange (Gain)/ Loss | (72) | 8 | |
Depreciation and Amortisation Expenses | 8,802 | 8,959 | |
Lease Rentals received | (124) | (124) | |
Net (gain)/loss on disposal of property, plant and equipment | 0 | 14 | |
Interest Income On Financial Assets at Amortized Cost | (1,598) | (880) | |
Finance Cost | 257 | 304 | |
Bad Debts Written Off/ Provision for Doubtful Debts | 20 | 167 | |
Provisions no Longer Required Written Back | (119) | - | |
Interest income from Unwinding of discount on security deposits | (55) | (27) | |
Employee share-based payment expense | 339 | 541 | |
Operating Profit before Working Capital Changes | 73,105 | 76,469 | |
Adjustment for Increase/Decrease in Working Capital: | |||
(Increase) in Inventories | (1,125) | (186) | |
Decrease in Financial Assets | 7,565 | 52,960 | |
(Increase) / Decrease in Other Assets | (1,891) | 112 | |
Increase in Financial Liabilities | 10,231 | 3,649 | |
(Decrease) in Other Liabilities and Provisions | (2,556) | (2,190) | |
Cash Generated from Operations | 85,329 | 130,814 | |
Direct Taxes Paid (Net) | (15,300) | (16,914) | |
Net Cash Generated from Operating Activities (A) | 70,029 | 113,900 | |
Cash Flow from Investing Activities: | |||
Purchase of Property, Plant and Equipment | (3,639) | (3,809) | |
Proceeds from disposal of Property, Plant and Equipment | 1 | - | |
Purchase of Current Investments / Proceeds from disposal of Current Investments | 10,068 | (9,926) | |
Lease Rentals received | 124 | 124 | |
Proceeds from disposal of Non-Current Investments | 5 | - | |
Interest Received | 1,576 | 714 | |
Net Cash (used in)/ Cash flow from Investing Activities (B) | 8,135 | (12,897) | |
Cash Flow from Financing Activities: | |||
Dividends Paid | (56,893) | (54,145) | |
Payment of Lease Liabilities | (401) | (125) | |
Employee share-based payments | (361) | (285) | |
Net Cash used in Financing Activities (C) | (57,655) | (54,555) | |
Net increase/ (decrease) in Cash and Cash Equivalents (A+B+C) | 20,509 | 46,448 | |
Cash and Cash Equivalents at April 1 | 72,407 | 29,657 | |
Cash and Cash Equivalents at September 30 | 92,916 | 76,105 | |
Bank Balances in: | |||
Current Accounts | 587 | 1,123 | |
Deposit Accounts (with less than 3 months original maturity) | 92,329 | 74,982 | |
Cash and Cash Equivalents at September 30 | 92,916 | 76,105 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Colgate-Palmolive (India) Limited published this content on 20 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 October 2022 08:39:05 UTC.